State of Tennessee, Department of Treasury
EGRX

State of Tennessee, Department of Treasury’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,538
Closed -$68.8K – 1749
2023
Q2 		$68.8K Sell
3,538
-2,618
-43% -$62.1K ﹤0.01% 1687
2023
Q1 		$175K Sell
6,156
-2,189
-26% -$65K ﹤0.01% 1560
2022
Q4 		$244K Buy
8,345
+328
+4% +$10.4K ﹤0.01% 1494
2022
Q3 		$212K Buy
8,017
+390
+5% +$14.3K ﹤0.01% 1522
2022
Q2 		$339K Sell
7,627
-64
-0.8% -$2.94K ﹤0.01% 1428
2022
Q1 		$381K Buy
7,691
+645
+9% +$31K ﹤0.01% 1474
2021
Q4 		$359K Buy
7,046
+407
+6% +$21.1K ﹤0.01% 1461
2021
Q3 		$371K Sell
6,639
-398
-6% -$19.6K ﹤0.01% 1442
2021
Q2 		$301K Sell
7,037
-27
-0.4% -$1.11K ﹤0.01% 1504
2021
Q1 		$295K Buy
7,064
+404
+6% +$18.8K ﹤0.01% 1458
2020
Q4 		$310K Buy
6,660
+569
+9% +$26.6K ﹤0.01% 1391
2020
Q3 		$258K Hold
6,091
– – ﹤0.01% 1341
2020
Q2 		$292K Sell
6,091
-524
-8% -$26.1K ﹤0.01% 1312
2020
Q1 		$304K Sell
6,615
-355
-5% -$17.8K ﹤0.01% 1257
2019
Q4 		$419K Sell
6,970
-1,128
-14% -$67.3K ﹤0.01% 1313
2019
Q3 		$458K Buy
8,098
+552
+7% +$31K ﹤0.01% 1303
2019
Q2 		$420K Sell
7,546
-155
-2% -$8.08K ﹤0.01% 1259
2019
Q1 		$389K Sell
7,701
-209
-3% -$9.3K ﹤0.01% 1313
2018
Q4 		$319K Buy
7,910
+1,879
+31% +$96.8K ﹤0.01% 1322
2018
Q3 		$418K Buy
6,031
+253
+4% +$19.2K ﹤0.01% 1341
2018
Q2 		$437K Sell
5,778
-202
-3% -$12.7K ﹤0.01% 1351
2018
Q1 		$315K Sell
5,980
-369
-6% -$21.5K ﹤0.01% 1398
2017
Q4 		$339K Sell
6,349
-691
-10% -$38.5K ﹤0.01% 1425
2017
Q3 		$420K Sell
7,040
-445
-6% -$26.9K ﹤0.01% 1362
2017
Q2 		$590K Hold
7,485
– – ﹤0.01% 1314
2017
Q1 		$621K Buy
7,485
+1,130
+18% +$84K ﹤0.01% 1304
2016
Q4 		$504K Hold
6,355
– – ﹤0.01% 1345
2016
Q3 		$445K Buy
+6,355
New +$352K ﹤0.01% 1283

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State of Tennessee, Department of Treasury's EGRX Position: Q3 2023 in Review

State of Tennessee, Department of Treasury sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2023, closing a stake of 3,538 shares — an estimated $68.8K sold.

State of Tennessee, Department of Treasury first reported a position in EGRX in Q3 2016 and held it in 28 quarters. The position peaked at $621K in Q1 2017. 107 funds tracked by Wall St. Rank hold EGRX as of Q3 2023.

  • State of Tennessee, Department of Treasury reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 3,538 Eagle Pharmaceuticals, Inc. shares in Q3 2023, an estimated $68.8K.
  • State of Tennessee, Department of Treasury first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2016 and held it in 28 quarters.
  • State of Tennessee, Department of Treasury's Eagle Pharmaceuticals, Inc. position peaked at $621K in Q1 2017.
  • 107 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2023.

Based on State of Tennessee, Department of Treasury's 13F filing for Q3 2023, filed 14 Nov 2023.